Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -79.68% is 55% below its 5-year average of -51.57%, near the low end of its 5-year range (-96.93%–-10.72%).
As of the fiscal period ended Tuesday, June 30, 2026. 2.81% above its 12-month average of -81.98%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -79.68%.
RETURN ON INVESTED CAPITAL (ROIC)
-79.68%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-81.98%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-70.32%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-51.57%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-48.37%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-29.60%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+2.81%
CURRENT VS 3Y AVG
-13.31%
CURRENT VS 5Y AVG
-54.50%
CURRENT VS 10Y AVG
-64.73%
CURRENT VS 15Y AVG
-169.15%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
-123.43%
vs the sector median at left
Adicet Bio, Inc.
Market Cap
$58.43M
Return on Invested Capital (ROIC)
-79.68%
TTM Avg
-81.98%
3Y Avg
-70.32%
5Y Avg
-51.57%
Market Cap
$58.44M
Return on Invested Capital (ROIC)
-3699.99%
TTM Avg
-104.88%
3Y Avg
-89.50%
5Y Avg
-74.29%
Market Cap
$58.29M
Return on Invested Capital (ROIC)
-604.20%
TTM Avg
-195.52%
3Y Avg
-273.84%
5Y Avg
-208.65%
Market Cap
$58.06M
Return on Invested Capital (ROIC)
-52.40%
TTM Avg
-44.92%
3Y Avg
-44.92%
5Y Avg
-44.02%
Market Cap
$57.76M
Return on Invested Capital (ROIC)
-43.97%
TTM Avg
-40.46%
3Y Avg
-48.41%
5Y Avg
-43.33%
Market Cap
$59.18M
Return on Invested Capital (ROIC)
-26.13%
TTM Avg
-90.47%
3Y Avg
-104.07%
5Y Avg
-130.48%
Market Cap
$57.61M
Return on Invested Capital (ROIC)
-65.20%
TTM Avg
-74.94%
3Y Avg
-77.07%
5Y Avg
-67.70%
Market Cap
$57.01M
Return on Invested Capital (ROIC)
-136.77%
TTM Avg
-80.48%
3Y Avg
-75.99%
5Y Avg
-77.22%
Market Cap
$60.02M
Return on Invested Capital (ROIC)
-1235.48%
TTM Avg
-801.38%
3Y Avg
-433.95%
5Y Avg
-312.84%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Adicet Bio, Inc. (ACET) | $58.43M | -79.68% | -81.98% | -70.32% | -51.57% |
| PDS Biotechnology Corporation (PDSB)vs › | $58.44M | -3699.99% | -104.88% | -89.50% | -74.29% |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.29M | -604.20% | -195.52% | -273.84% | -208.65% |
| Kalaris Therapeutics Inc (KLRS)vs › | $58.06M | -52.40% | -44.92% | -44.92% | -44.02% |
| Boundless Bio, Inc. (BOLD)vs › | $57.76M | -43.97% | -40.46% | -48.41% | -43.33% |
| Xilio Therapeutics, Inc. (XLO)vs › | $59.18M | -26.13% | -90.47% | -104.07% | -130.48% |
| Talphera, Inc. (TLPH)vs › | $57.61M | -65.20% | -74.94% | -77.07% | -67.70% |
| Connect Biopharma Holdings Limited (CNTB)vs › | $57.01M | -136.77% | -80.48% | -75.99% | -77.22% |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.02M | -1235.48% | -801.38% | -433.95% | -312.84% |
| Fractyl Health, Inc. (GUTS)vs › | $60.42M | -129.67% | -97.71% | -90.63% | -82.49% |
ROIC
-79.7%
ROE
-82.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -79.68% |
| 2026-03-31 | -75.32% |
| 2025-12-31 | -71.49% |
| 2025-09-30 | -96.93% |
| 2025-06-30 | -86.48% |
| 2025-03-31 | -72.43% |
| 2024-12-31 | -63.55% |
| 2024-09-30 | -56.69% |
| 2024-06-30 | -58.80% |
| 2024-03-31 | -54.27% |
| 2023-12-31 | -80.87% |
| 2023-09-30 | -70.19% |
| 2023-06-30 | -47.44% |
| 2023-03-31 | -38.55% |
| 2022-12-31 | -23.33% |
| 2022-09-30 | -16.65% |
| 2022-06-30 | -15.07% |
| 2022-03-31 | -10.72% |
| 2021-12-31 | -19.04% |
| 2021-09-30 | -23.29% |
| 2021-06-30 | -22.17% |
| 2021-03-31 | -20.63% |
| 2020-12-31 | -29.56% |
| 2020-09-30 | -30.77% |
| 2020-06-30 | -54.52% |
| 2020-03-31 | -45.71% |
| 2019-12-31 | -47.04% |
| 2019-09-30 | -103.11% |
| 2019-06-30 | -84.27% |
| 2019-03-31 | -82.92% |
| 2018-12-31 | -117.36% |
| 2018-09-30 | -92.80% |
| 2018-06-30 | -82.26% |
| 2018-03-31 | -36.51% |
| 2017-12-31 | -48.74% |
| 2017-06-30 | 4.51% |
| 2017-03-31 | 2.42% |
| 2016-12-31 | 2.70% |
| 2016-09-30 | 6.87% |
| 2016-06-30 | 7.92% |
| 2016-03-31 | 8.41% |
| 2015-12-31 | 8.32% |
| 2015-09-30 | 8.54% |
| 2015-06-30 | 7.66% |
| 2015-03-31 | 7.61% |
| 2014-12-31 | 6.33% |
| 2014-09-30 | 6.39% |
| 2014-06-30 | 8.03% |
| 2014-03-31 | 10.94% |
| 2013-12-31 | 12.10% |
| 2013-09-30 | 11.39% |
| 2013-06-30 | 9.07% |
| 2013-03-31 | 8.40% |
| 2012-12-31 | 7.64% |
| 2012-09-30 | 7.93% |
| 2012-06-30 | 7.49% |
| 2012-03-31 | 7.18% |
| 2011-12-31 | 6.68% |
| 2011-09-30 | 4.19% |
| 2011-06-30 | 4.30% |
| 2011-03-31 | 4.48% |
| 2010-12-31 | 4.49% |
| 2010-09-30 | 5.01% |
| 2010-06-30 | 4.29% |
| 2010-03-31 | 2.06% |
| 2009-12-31 | 1.09% |
| 2009-09-30 | 3.31% |
| 2009-06-30 | 5.66% |
| 2009-03-31 | 10.72% |
| 2008-12-31 | 11.25% |
| 2008-09-30 | 11.33% |
